Zika Virus Overview and Impact
85 Questions
0 Views

Zika Virus Overview and Impact

Created by
@RenewedReasoning

Podcast Beta

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What has been shown to be effective in preventing ZIKV acquisition?

  • Previous infections
  • Neutralizing antibodies from vaccines (correct)
  • Genetic polymorphisms
  • Lifestyle changes

    • Which stages of clinical trials have candidate ZIKV vaccines completed?

  • Phase III and IV
  • Phase II and IV
  • Phase I and III
  • Phase I and II (correct)

    • In which models has ZIKV's dynamics of viral replication been studied?

  • Human clinical trials
  • Cell cultures only
  • Rhesus macaque and non-human primates (correct)
  • Mice and rabbits

    • What action did the World Health Organization take regarding the ZIKV epidemic?

    <p>Declared an end to the epidemic</p> Signup and view all the answers

    Which type of contact has not been associated with ZIKV transmission, as per the content provided?

    <p>Respiratory droplets</p> Signup and view all the answers

    Why is vaccine development for ZIKV still a high priority?

    <p>ZIKV remains a concern despite low levels</p> Signup and view all the answers

    What characteristic of the rhesus macaque model is highlighted in the content?

    <p>It consistently reproduces features of ZIKV infection</p> Signup and view all the answers

    What does the presence of genetic polymorphisms relate to in the context of ZIKV?

    <p>Development of Congenital Zika Syndrome (CZS)</p> Signup and view all the answers

    What is the primary benefit of vaccination against ZIKV for pregnant rhesus macaques?

    <p>It prevents ZIKV distribution to fetal tissues.</p> Signup and view all the answers

    What was a significant consequence of ZIKV outbreaks in Brazil in late 2015?

    <p>An increase in cases of congenital ZIKA syndrome.</p> Signup and view all the answers

    Which type of antibodies are associated with vaccine efficacy in preventing ZIKV in pregnant rhesus macaques?

    <p>ZIKV neutralizing antibodies.</p> Signup and view all the answers

    ZIKV is primarily transmitted through which vector?

    <p>Aedes mosquitoes.</p> Signup and view all the answers

    What does CDC guidance recommend for pregnant women regarding travel to areas with ZIKV outbreaks?

    <p>They should consult with medical providers before traveling.</p> Signup and view all the answers

    What limiting factor currently affects the establishment of clinical trial sites for ZIKV vaccines?

    <p>Current low levels of ZIKV worldwide.</p> Signup and view all the answers

    Which virus family does ZIKV belong to?

    <p>Flaviviridae.</p> Signup and view all the answers

    Why is the development of a ZIKV vaccine considered feasible?

    <p>Research indicates a strong immune response can be generated.</p> Signup and view all the answers

    What was the method used to analyze the IFNγ ELISPOT responses in the study?

    <p>Friedman one-way ANOVA</p> Signup and view all the answers

    What was the criterion for indicating responses above 50 SFU per 106 PBMCs?

    <p>A dotted line</p> Signup and view all the answers

    What percentage of fetuses from non-vaccinated dams showed evidence of viral replication in tissues?

    <p>20%</p> Signup and view all the answers

    What characteristic of fetuses born to Ad26.M.Env vaccinated dams was confirmed via sonography?

    <p>Normal biometric parameters</p> Signup and view all the answers

    What was the timeframe after immunization in which colored responses were noted for the dams?

    <p>10 weeks to 22 weeks</p> Signup and view all the answers

    What type of animal was used in the study to evaluate the immunization effects?

    <p>Pregnant macaques</p> Signup and view all the answers

    What was the main purpose of collecting fetal tissues at necropsy?

    <p>To check for vRNA evidence</p> Signup and view all the answers

    How many fetuses from vaccinated dams were reported to have no evidence of viral replication in tissues?

    <p>5 out of 5</p> Signup and view all the answers

    What is a primary concern regarding the immunity provided by the Ad26 Ebola vaccine over time?

    <p>Immunity may wane, leading to re-emergence of ZIKV.</p> Signup and view all the answers

    Which mosquito species is identified as a vector for ZIKV in the southern United States?

    <p>Aedes aegypti</p> Signup and view all the answers

    What is the status of the Ad26.M.Env vaccine in relation to safety and tolerability based on the Phase I clinical trial?

    <p>Well tolerated with no safety concerns identified.</p> Signup and view all the answers

    What type of responses did the Ad26.M.Env vaccine induce in study participants?

    <p>Robust ZIKV neutralizing titers similar to macaques.</p> Signup and view all the answers

    What challenge is posed by the lack of exposure to ZIKV during the 2016 epidemic for the U.S. population?

    <p>Heightened vulnerability to future ZIKV epidemics.</p> Signup and view all the answers

    Which type of vaccines have been shown to be immunogenic and protective against ZIKV?

    <p>mRNA based vaccines.</p> Signup and view all the answers

    What was the outcome of transferring immune sera from vaccinated study participants to mice?

    <p>Mice were protected against ZIKV vRNA in blood.</p> Signup and view all the answers

    What is a key consideration for developing vaccines to protect naïve individuals during future ZIKV outbreaks?

    <p>Developing a well-tolerated and safe vaccine.</p> Signup and view all the answers

    What was the mean peak vRNA level found on day 7 post-amniocentesis samples?

    <p>5.5 log10</p> Signup and view all the answers

    How long did non-vaccinated, challenged animals have detectable virus on average?

    <p>42 days</p> Signup and view all the answers

    What method was used to measure fetal biometric analyses in dams after confirmation of pregnancy?

    <p>Biparietal diameter</p> Signup and view all the answers

    Which sample types were reported to be negative for ZIKV vRNA?

    <p>Saliva and vaginal</p> Signup and view all the answers

    What type of immune response does the Ad26.M.Env vaccine induce?

    <p>Cellular immune anti-Env response</p> Signup and view all the answers

    How many weeks was the vaccination response measured after immunization?

    <p>4 weeks</p> Signup and view all the answers

    Which of the following was NOT mentioned as a type of sample collected?

    <p>Amniotic fluid</p> Signup and view all the answers

    After vaccination, what was observed in all samples from the challenged dams?

    <p>Negative for ZIKV vRNA</p> Signup and view all the answers

    In which animals was the peak vRNA reported?

    <p>Challenged dams regardless of vaccination status</p> Signup and view all the answers

    What was the focus of the monitoring conducted on dams post-pregnancy confirmation?

    <p>Fetal biometric analyses</p> Signup and view all the answers

    Which specific immune response was examined in the statistical figures?

    <p>Env specific Cellular IFN- response</p> Signup and view all the answers

    What was the detectable viral load trend over the 42 days observed in non-vaccinated challenged animals?

    <p>Gradually decreasing</p> Signup and view all the answers

    Which of the following was NOT a response measured post-vaccination?

    <p>Immune pressure</p> Signup and view all the answers

    Neonates born to vaccinated dams had evidence of ZIKV vRNA in their tissues.

    <p>False</p> Signup and view all the answers

    Fetal biometric parameters showed abnormalities in all study groups.

    <p>False</p> Signup and view all the answers

    C-section was performed approximately 2 weeks before the estimated delivery date.

    <p>True</p> Signup and view all the answers

    Vaccinated animals showed no detectable anti-Env cellular immune responses prior to challenge.

    <p>False</p> Signup and view all the answers

    The geometric mean response per group was indicated with a vertical line.

    <p>False</p> Signup and view all the answers

    2 out of 5 fetuses from non-vaccinated dams had evidence of viral replication in tissues.

    <p>True</p> Signup and view all the answers

    No adverse events were reported in either the vaccinated or non-vaccinated groups prior to the ZIKV challenge.

    <p>True</p> Signup and view all the answers

    Responses above 50 SFU per 106 PBMCs were indicated by a solid line.

    <p>False</p> Signup and view all the answers

    Pregnant females in the non-vaccinated group were not infected with Zika virus.

    <p>False</p> Signup and view all the answers

    Fetal brain weights and body weight ratios were similar across all groups studied.

    <p>True</p> Signup and view all the answers

    Vaccinated dams had detectable virus in confirmed pregnancy.

    <p>False</p> Signup and view all the answers

    All samples from challenged dams showed evidence of ZIKV vRNA after vaccination.

    <p>False</p> Signup and view all the answers

    The prM-specific cellular responses were noted to be generally high in both groups.

    <p>False</p> Signup and view all the answers

    Animal monitoring included evaluation of white blood cell count and total lymphocyte counts.

    <p>True</p> Signup and view all the answers

    Some animals experienced trauma that required clinical intervention, which was linked to vaccination status.

    <p>False</p> Signup and view all the answers

    Animals in the vaccinated group maintained normal reference ranges throughout the study period.

    <p>True</p> Signup and view all the answers

    The Ad26 Ebola vaccine is recommended as a childhood vaccine in Ebola endemic regions.

    <p>True</p> Signup and view all the answers

    A lack of exposure to ZIKV in the US population during the 2016 epidemic makes individuals immune to future outbreaks.

    <p>False</p> Signup and view all the answers

    Aedes aegypti mosquitoes are primarily found in the northern United States.

    <p>False</p> Signup and view all the answers

    The Ad26.M.Env vaccine was found to have safety concerns during clinical trials.

    <p>False</p> Signup and view all the answers

    The development of a well-tolerated vaccine for ZIKV is essential for protecting naïve individuals.

    <p>True</p> Signup and view all the answers

    Adenoviral based vaccines have shown variable efficacy in inducing neutralizing antibody responses in monkeys.

    <p>True</p> Signup and view all the answers

    Transferring immune sera from vaccinated study participants to mice resulted in protection against ZIKV.

    <p>True</p> Signup and view all the answers

    Immune-mediated thrombocytopenia and thrombosis have been fully understood regarding their mechanisms after COVID-19 vaccinations.

    <p>False</p> Signup and view all the answers

    A significant consequence of the ZIKV study included the detection of viral replication in the tissues of all fetuses from vaccinated dams.

    <p>False</p> Signup and view all the answers

    The Ad26.M.Env vaccine was produced using the human PER.C61 cell line.

    <p>True</p> Signup and view all the answers

    The live infants delivered to the vaccinated group included a total of six males.

    <p>False</p> Signup and view all the answers

    ZIKV-specific neutralizing antibodies were measured using fold reduction neutralization assays.

    <p>True</p> Signup and view all the answers

    Reproductive failure rates were observed to be outside the historical control range for primates in the study.

    <p>False</p> Signup and view all the answers

    All dams and fetuses in the study were euthanized for physiological assessments.

    <p>True</p> Signup and view all the answers

    A total of five live male infants and three live female infants were delivered to the non-vaccinated, challenged group.

    <p>False</p> Signup and view all the answers

    The virus input for the assays was incubated with serum samples for one hour at 37 °C.

    <p>True</p> Signup and view all the answers

    Optical density at 280 nm was used to determine Ad26 particle concentrations.

    <p>False</p> Signup and view all the answers

    Microneutralization assays involve serially diluting serum samples in a total volume of 100 uL.

    <p>True</p> Signup and view all the answers

    Vero cells were maintained in EMEM media supplemented with 10% FBS.

    <p>True</p> Signup and view all the answers

    Ultrasounds were performed only on ZIKV-infected pregnant rhesus monkeys.

    <p>False</p> Signup and view all the answers

    The absorbance during cell development was read at 550 nm.

    <p>False</p> Signup and view all the answers

    Serum/virus mixtures were incubated with Vero cell monolayers for 1 hour at 35 °C.

    <p>False</p> Signup and view all the answers

    Animals were sedated with Telazol at a dose of 10 mg/kg for the procedures.

    <p>False</p> Signup and view all the answers

    The monoclonal antibody 6B6-C1 was developed with HRP for the assays.

    <p>True</p> Signup and view all the answers

    Study Notes

    Zika Virus (ZIKV) and its Impact

    • ZIKV is a member of the Flaviviridae family, first identified in Uganda in 1954.
    • Prior to 2015, ZIKV was associated with mild, flu-like symptoms.
    • In late 2015, a ZIKV epidemic in Brazil led to a surge in cases of fetal microcephaly, prompting global efforts to develop a vaccine.
    • ZIKV is primarily spread through Aedes mosquitos, but can also be transmitted transplacentally, through blood transfusions, and sexually.
    • Genetic polymorphisms have been linked to the development of congenital Zika syndrome (CZS).
    • The World Health Organization (WHO) declared the end of the ZIKV epidemic in late 2016, but vaccine development remains a priority due to the potential for resurgence.
    • ZIKV is a concern for individuals traveling to or living in endemic areas, particularly pregnant women.
    • While ZIKV transmission is currently at low levels, vaccine development is challenging due to the difficulty in establishing clinical trial sites and enrolling participants.

    Vaccine Development and Research

    • Vaccination prevents ZIKV distribution to fetal tissues, including the brain.
    • ZIKV-associated neuropathology was absent in offspring of Ad26.M.Env vaccinated dams, while pathology was limited in fetuses from unvaccinated, challenged dams.
    • Vaccine efficacy is linked to the induction of ZIKV neutralizing antibodies in pregnant rhesus macaques.
    • Clinical trials for ZIKV vaccines are underway, with several candidates completing Phase I and II safety studies.
    • The rhesus macaque model has proven useful in studying the dynamics of viral replication and shedding during ZIKV infection.
    • Studies in mice and non-human primates have demonstrated that inducing neutralizing antibodies through various vaccine platforms effectively prevents ZIKV acquisition.

    Future Directions

    • Ideally, a ZIKV vaccine could be deployed quickly in the event of a resurgence and administered safely to pregnant women.
    • Continued research and development are crucial for creating an effective and readily available ZIKV vaccine to protect vulnerable populations from the devastating effects of CZS.

    Study Background

    • The study investigated the effectiveness of an investigational Ad26.M.Env vaccine against Zika virus (ZIKV) in pregnant macaques.
    • The vaccine used a modified adenovirus type 26 (Ad26) vector expressing the ZIKV envelope (Env) protein as a potential ZIKV immunogen.
    • The study compared the vaccine's effect on vaccinated pregnant macaques versus unvaccinated pregnant macaques challenged with ZIKV.

    Vaccine Efficacy

    • Following ZIKV challenge, both vaccinated and unvaccinated macaques exhibited peak viral RNA (vRNA) levels on day 7 post-challenge.
    • Importantly, all vaccinated macaques remained negative for detectable vRNA in body fluids (colorectal, vaginal, saliva) throughout the study.
    • In contrast, unvaccinated macaques showed detectable viral loads for an average of 42 days.

    Immune Responses

    • The Ad26.M.Env vaccine induced low-level cellular immune responses, primarily against the Env protein, in vaccinated pregnant macaques.
    • The study measured interferon-gamma (IFNγ) production by peripheral blood mononuclear cells (PBMCs) as an indicator of cellular immunity.
    • Although responses were generally lower than expected, they indicated some degree of immune priming by the vaccine.

    Fetal Development

    • The researchers closely monitored fetal development using ultrasound throughout the pregnancies.
    • No significant differences were observed in fetal biometric parameters or brain development between vaccinated and unvaccinated macaques.
    • This suggests that the vaccine did not adversely affect fetal growth or neurological development in pregnant macaques.

    Protection from ZIKV Infection

    • At term, all fetuses born to vaccinated dams were negative for ZIKV vRNA, indicating complete protection from ZIKV infection.
    • Histopathological evaluation of fetal tissues revealed no evidence of viral replication in any of the vaccinated fetuses.
    • In contrast, two out of five unvaccinated dams gave birth to fetuses with detectable ZIKV vRNA in their tissues, suggesting transmission from the infected mothers.

    Summary

    • These results demonstrate that the Ad26.M.Env vaccine effectively protected pregnant macaques from ZIKV infection and prevented vertical transmission to their offspring.
    • While the vaccine induced lower than expected immune responses, it proved sufficient to confer complete protection against ZIKV infection in this animal model.
    • Further research is warranted to optimize the vaccine and explore its potential application in human pregnancies.

    Adenovirus-based Vaccines for Zika Virus

    • An Ad26.ZEBOV Ebola vaccine is licensed and recommended for childhood use in Ebola endemic regions.
    • The Ad26.M.Env (Ad26.ZIKV.001) vaccine for Zika Virus has been tested in a Phase I clinical trial.
    • All tested vaccine regimens were well-tolerated, with no safety concerns identified.
    • Vaccination with Ad26.M.Env induced robust Zika Virus neutralizing titers in humans similar to those achieved in macaques.
    • Immune sera from vaccinated humans transferred to mice could protect mice against Zika Virus.
    • Adenoviral-based vaccines combatting COVID-19 were associated with immune-mediated thrombocytopenia and thrombosis.
    • The mechanisms for these adverse effects remain unclear.
    • Further research is required to determine if these adverse effects are linked to the interaction between the Adenovirus-based vaccine and the COVID-19 spike protein, or the Adenovirus vaccine platform itself.
    • Adenoviral constructs are still widely studied and will likely remain an important platform for global use.

    Zika Virus Pandemic Risk

    • Previous Zika Virus outbreaks in Malaysia have shown a cyclical re-emergence due to waning immunity over time.
    • The United States faces a risk of future Zika Virus pandemics due to the presence of the Aedes aegypti mosquito vector in the Southern United States.
    • The lack of exposure to Zika Virus during the 2016 epidemic makes the US population vulnerable to future outbreaks.
    • A well-tolerated and safe vaccine is needed for pre- and perinatal use to protect susceptible individuals.

    mRNA-based Zika Virus Vaccines

    • mRNA-based vaccines against Zika Virus have demonstrated immunogenicity and protective effects in non-human primate challenge studies.
    • These vaccines have shown variable efficacy in inducing neutralizing antibody responses in humans.

    Ad26.M.Env Vaccine and Protection Against Zika Virus in Pregnant Macaques

    • A study investigated the safety and efficacy of an Ad26.M.Env vaccine against Zika virus (ZIKV) in pregnant rhesus macaques.
    • Pregnant macaques were divided into two groups: vaccinated with Ad26.M.Env and non-vaccinated control.
    • Both groups were challenged with ZIKV at 6 weeks post-conception (~10-30 weeks post-vaccination).
    • Key finding: Vaccinated dams remained completely protected from ZIKV infection in blood and tissues.
    • Key finding: All fetuses born to vaccinated dams were also negative for ZIKV, and had no ZIKV-associated histopathological abnormalities.
    • Key finding: Non-vaccinated dams and their fetuses exhibited ZIKV infection.
    • The study suggests that the Ad26.M.Env vaccine is safe and efficacious in protecting pregnant macaques and their fetuses from ZIKV infection.
    • The Ad26.M.Env vaccine elicited strong cellular immune responses in vaccinated animals.
    • The vaccine also induced robust ZIKV neutralizing antibody titers, comparable to human volunteers in a Phase 1 clinical trial.

    Neutralization Assays

    • The study measured ZIKV-specific neutralizing antibodies using two methods: fold reduction neutralization (FRNT) and micro-neutralization (MN) assays.
    • FRNT assay is based on the principle of measuring the reduction in virus infectivity after exposure to serum containing neutralizing antibodies
    • MN assay involves serially diluting serum samples in microplates, adding ZIKV, and then observing the effect of the serum on viral replication in Vero cells.
    • Both FRNT and MN assays confirmed the presence of neutralizing antibodies in vaccinated animals.

    Zika Virus Challenge

    • ZIKV challenge stock was prepared from the 2015 Brazilian epidemic strain.
    • Pregnant macaques were infected with 1x103 PFU (1×106 vp) of ZIKV via subcutaneous route at 6 weeks post-conception.

    Clinical Monitoring

    • All animals were monitored for clinical signs, body weight, and complete blood cell count (CBC) throughout the study period.
    • Ultrasonography was performed bi-weekly to assess pregnancy status and fetal development.
    • No serious adverse events were reported in relation to vaccination or ZIKV challenge.

    Fetal Evaluation

    • Dam were euthanized at term and fetuses underwent C-section.
    • Fetal and placental tissues were collected for histopathology, viral RNA analysis, and gross examination.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    ZIKV Vaccine Protects NHP & Fetus PDF

    Description

    Explore the Zika Virus (ZIKV), its history, and its significant impact on public health. This quiz covers its transmission methods, epidemic history, and the ongoing vaccine development efforts. Understand the implications for travelers and pregnant women in endemic regions.

    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser